MetLife Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$557K Hold
76,212
﹤0.01% 1625
2025
Q1
$723K Sell
76,212
-1,191
-2% -$11.3K ﹤0.01% 1523
2024
Q4
$1.28M Buy
77,403
+2,596
+3% +$42.8K 0.01% 1296
2024
Q3
$1.1M Hold
74,807
0.01% 1340
2024
Q2
$1.04M Buy
74,807
+7,465
+11% +$104K 0.01% 1326
2024
Q1
$1.06M Hold
67,342
0.01% 1265
2023
Q4
$1.09M Hold
67,342
0.01% 1252
2023
Q3
$828K Hold
67,342
0.01% 1343
2023
Q2
$1.08M Buy
67,342
+906
+1% +$14.6K 0.01% 1226
2023
Q1
$1.16M Hold
66,436
0.01% 1156
2022
Q4
$614K Buy
66,436
+1,124
+2% +$10.4K ﹤0.01% 1513
2022
Q3
$562K Buy
65,312
+3,803
+6% +$32.7K ﹤0.01% 1554
2022
Q2
$501K Hold
61,509
﹤0.01% 1658
2022
Q1
$747K Buy
61,509
+22,424
+57% +$272K ﹤0.01% 1516
2021
Q4
$1.33M Hold
39,085
0.01% 1015
2021
Q3
$1.89M Sell
39,085
-1,733
-4% -$83.6K 0.02% 882
2021
Q2
$1.84M Hold
40,818
0.02% 912
2021
Q1
$1.97M Sell
40,818
-1,897
-4% -$91.5K 0.02% 878
2020
Q4
$2.3M Sell
42,715
-3,060
-7% -$165K 0.02% 757
2020
Q3
$1.69M Hold
45,775
0.02% 792
2020
Q2
$1.42M Buy
45,775
+5,912
+15% +$183K 0.02% 879
2020
Q1
$1.1M Sell
39,863
-2,300
-5% -$63.5K 0.02% 863
2019
Q4
$1.23M Hold
42,163
0.01% 990
2019
Q3
$806K Buy
42,163
+2,474
+6% +$47.3K 0.01% 1171
2019
Q2
$871K Buy
39,689
+3,051
+8% +$66.9K 0.01% 1173
2019
Q1
$750K Buy
36,638
+10,141
+38% +$207K 0.01% 1212
2018
Q4
$334K Hold
26,497
﹤0.01% 1612
2018
Q3
$407K Hold
26,497
﹤0.01% 1661
2018
Q2
$347K Hold
26,497
﹤0.01% 1630
2018
Q1
$216K Hold
26,497
﹤0.01% 1846
2017
Q4
$235K Buy
+26,497
New +$235K ﹤0.01% 1848